Cosmetics Europe Conference 2022
Monday, December 13, 2021SCCS

SCCS: Scientific advice on the safety of Homosalate

CSSC : Avis scientifique sur la sécurité de l'Homosalate

Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disrupting properties, the Scientific Committee has just published its Scientific advice on Homosalate (UV-Filter). It was adopted by written procedure on 2 December 2021 in its final version and is not open for comments.

Reading time
~ 2 minutes


Homosalate (CAS No.118-56-9, EC No.204-260-8) has been evaluated for its safety by the SCCP in 2007 (SCCP/1086/07) and is currently regulated as a UV-filter in sunscreen products in a concentration up to 10 % (Annex VI/3).
On 24-25 June 2021, the SCCS adopted an Opinion (SCCS/1622/20) concluding that Homosalate could not be considered safe at concentrations of up to 10%. According to the SCCS’s Opinion, the use of Homosalate is safe for the consumer up to a maximum concentration of 0.5% in the final product.
On 30 July 2021, in order to ensure broad availability of UV-filters and consequently adequate sun protection for consumers, industry submitted a re-calculation of the Margin of Safety (MoS) based only on the use of Homosalate in face products (face cream and pump-spray products).

For an exhaustive background information, see the articles
Homosalate: Final Opinion of the SCCS, CosmeticOBS, 5 July 2021
Butylparaben, Homosalate: requests for SCCS Opinions, CosmetiOBS, 19 October 2021


1. In light of the information provided and taking under consideration the concerns related to potential endocrine disrupting properties of Homosalate, does the SCCS consider Homosalate safe when used as a UV-filter in face products (face cream …

This content is only available to subscribersPREMIUM, PRO, STARTUPandTPE

Already subscribed?Log in

Discover our subscriptions

Best ingredient innovation of 2022

SCCSOther articles